Potentiometric analysis is that branch of electrochemical analysis dependant on the measurement of electrode potentials.
There are two sub-classes. The first is potentiometry where only one measurement of potential is made: here pH estimation is an important example. The second is potentiometric titration where the potentiometric procedure is used to follow the course of a volumetric titration and to indicate when the end point has been reached. Many examples of this type could be quoted from the four major divisions of titrimetric analysis i.e. those involving neutralisation, oxidation/reduction, precipitation and complex formation reactions.
The instrument for measuring potentials may be any type of potentiometer when 10\\ resistance metal electrodes are used, but when in addition pH measurements are made with a high resistance glass electrode, an electronic instrument e.g. a pH meter is necessary.
Titrators vary in complexity. They can be manually operated, automatic, or much more rarely, fully automatic. This last type, in addition to doing the automatic titration, also prepares the sample, records the results and cleans up ready for the next analysis. Automatic titrators may stop at a predetermined end-point and/or record the progress of the titration. A variety of commercial automatic titrators is available, some being suitable not only for a wide range of different analyses but also for analysing routinely up to 60 specimens per hour.
There are many clinical uses of potentiometric analysis, the following short list merely illustrating the range. Nowadays the demand for such a service has spread outside those hospitals where radiotherapy departments are situated, and biochemistry departments increasingly find themselves asked to carry out this form of investigation. This article deals with three types of problem encountered in establishing such a service, namely how to set about the preliminaries, what isotope to use and what measurements to take from the patients submitted for investigation.
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Before such a service can be started in the United Kingdom, reference should be made to the Secretary, The Clinical Advisory Panel (Isotopes), The Medical Research Council, 20 Park Crescent, London W.1., who will advise on the correct procedure for applying to the panel for the necessary approval, and will indicate what information is needed. Reference should also be made to the Ministry of Health circular HM (63) 14, for information about the steps to be taken to comply with the Radioactive Substances Act 1960, some provisions of which apply to hospitals as from December 1963. An explanatory memorandum is also available from H.M.S.O. which gives further information on this subject.
